🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The current study is being conducted by the Sponsor to evaluate the efficac...
Status
Completed
Location
First Choice Neurology - Aventura Neurologic Associates
Start Date
2022-10-05
Trial ID
NCT05189210
Treatments Being Tested
The goal of this study is to learn about the safety of 2 different amounts ...
Status
Completed
Location
Zhongshan Hospital,Fudan University-Dep. of Clinical Pharmacology (Site 0001)
Start Date
2023-11-22
Trial ID
NCT06843460
Treatments Being Tested
Study in participants with RA who have an inadequate response to methotrexa...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-30
Trial ID
NCT00950989
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy of blisibimo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02074020
Treatments Being Tested
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that regulates plasm...
Status
Unknown
Location
PLA General Hospital
Start Date
2015-07
Trial ID
NCT02490176
Treatments Being Tested
The purpose of this clinical trial was to evaluate efficacy and safety of o...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2023-03-03
Trial ID
NCT05598320
Treatments Being Tested
This is a Phase 1 study to assess the the safety, tolerability and pharmaco...
Status
Completed
Location
Research Site
Start Date
2022-04-04
Trial ID
NCT05351047
Treatments Being Tested
This Phase I randomized, double-blind, placebo-controlled clinical trial ev...
Status
Completed
Location
Limited Liability Partnership "Medcenter-Rakhat"
Start Date
2025-11-22
Trial ID
NCT07317960
The primary purpose of this study is to evaluate the efficacy of guselkumab...
Status
Completed
Location
Rheumatology Associates
Start Date
2017-07-12
Trial ID
NCT03158285
Treatments Being Tested
The overall hypothesis is that treatment with the SGLT2 inhibitor Ertuglifl...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2023-02-02
Trial ID
NCT05152940
Treatments Being Tested